OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study
Shinichi Imafuku, Chika Ohata, Yukari Okubo, et al.
Journal of Dermatological Science (2022) Vol. 105, Iss. 3, pp. 176-184
Closed Access | Times Cited: 12
Shinichi Imafuku, Chika Ohata, Yukari Okubo, et al.
Journal of Dermatological Science (2022) Vol. 105, Iss. 3, pp. 176-184
Closed Access | Times Cited: 12
Showing 12 citing articles:
Dimitrios Rigopoulos, Eleftheria Tampouratzi, Charalampos Angelakopoulos, et al.
Journal of the European Academy of Dermatology and Venereology (2024) Vol. 38, Iss. 6, pp. 1121-1130
Closed Access | Times Cited: 4
Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study
Chika Ohata, Yasumasa Kanai, Kenta Murotani, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1039-1052
Open Access | Times Cited: 8
Chika Ohata, Yasumasa Kanai, Kenta Murotani, et al.
Dermatology and Therapy (2023) Vol. 13, Iss. 4, pp. 1039-1052
Open Access | Times Cited: 8
A Promising Approach of Dermal Targeting of Antipsoriatic Drugs via Engineered Nanocarriers Drug Delivery Systems for Tackling Psoriasis
Devika Tripathi, Mansi Srivastava, Krislay Rathour, et al.
Drug Metabolism and Bioanalysis Letters (2023) Vol. 16, Iss. 2, pp. 89-104
Closed Access | Times Cited: 7
Devika Tripathi, Mansi Srivastava, Krislay Rathour, et al.
Drug Metabolism and Bioanalysis Letters (2023) Vol. 16, Iss. 2, pp. 89-104
Closed Access | Times Cited: 7
Single-Centre Real-World Study on Drug Survival and Effectiveness of Brodalumab for Treatment of Psoriasis and Psoriatic Arthritis
Cathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Drugs in R&D (2023) Vol. 23, Iss. 2, pp. 155-163
Open Access | Times Cited: 6
Cathrine Dawn Büttner Elgaard, Lars Iversen, Kasper Fjellhaugen Hjuler
Drugs in R&D (2023) Vol. 23, Iss. 2, pp. 155-163
Open Access | Times Cited: 6
Brodalumab for Plaque Psoriasis: A Canadian Real-World Experience at 2-Years Post-Launch
V. Gaudet, Belinda Yap, Shazia Hassan, et al.
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 3, pp. 226-235
Closed Access | Times Cited: 5
V. Gaudet, Belinda Yap, Shazia Hassan, et al.
Journal of Cutaneous Medicine and Surgery (2023) Vol. 27, Iss. 3, pp. 226-235
Closed Access | Times Cited: 5
Work productivity in real‐life employed patients with plaque psoriasis: Results from the ProLOGUE study
Hidehisa Saeki, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 49, Iss. 10, pp. 970-978
Open Access | Times Cited: 8
Hidehisa Saeki, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 49, Iss. 10, pp. 970-978
Open Access | Times Cited: 8
Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study
Takuya Miyagi, Yasumasa Kanai, Kenta Murotani, et al.
JAAD International (2022) Vol. 8, pp. 146-153
Open Access | Times Cited: 7
Takuya Miyagi, Yasumasa Kanai, Kenta Murotani, et al.
JAAD International (2022) Vol. 8, pp. 146-153
Open Access | Times Cited: 7
Real-world clinical outcomes of treatment with brodalumab in patients with moderate-to-severe psoriasis: a retrospective, 24-month experience from four academic dermatology centers in Greece
Evangelia Papadavid, Efterpi Zafeiriou, Sophia Georgiou, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 7, pp. 3053-3059
Closed Access | Times Cited: 5
Evangelia Papadavid, Efterpi Zafeiriou, Sophia Georgiou, et al.
Journal of Dermatological Treatment (2022) Vol. 33, Iss. 7, pp. 3053-3059
Closed Access | Times Cited: 5
Brodalumab: Efficacy, safety, and survival in mid‐term (52 weeks) on real clinical practice in Andalucia, Spain
Manuel Galán‐Gutiérrez, Pilar Font, Laura Padilla, et al.
International Journal of Dermatology (2022) Vol. 62, Iss. 5, pp. 700-706
Closed Access | Times Cited: 4
Manuel Galán‐Gutiérrez, Pilar Font, Laura Padilla, et al.
International Journal of Dermatology (2022) Vol. 62, Iss. 5, pp. 700-706
Closed Access | Times Cited: 4
Treatment with brodalumab is not associated with improved sleep problems in real‐life patients with plaque psoriasis: Results of the ProLOGUE study
Yoko Mizutani, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 3, pp. 319-326
Open Access | Times Cited: 2
Yoko Mizutani, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 3, pp. 319-326
Open Access | Times Cited: 2
Effectiveness of brodalumab in improving itching and skin pain in Japanese patients with psoriasis: The ProLOGUE study
Masaru Honma, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 4, pp. 453-461
Closed Access | Times Cited: 2
Masaru Honma, Yasumasa Kanai, Kenta Murotani, et al.
The Journal of Dermatology (2022) Vol. 50, Iss. 4, pp. 453-461
Closed Access | Times Cited: 2
Management of Moderate to Severe Plaque Psoriasis with Brodalumab in Daily Practice: Real-World Evidence from the LIBERO Study in the Czech Republic
Spyridon Gkalpakiotis, Martina Kojanová, Jorga Fialová, et al.
Dermatology and Therapy (2023) Vol. 14, Iss. 1, pp. 115-130
Open Access
Spyridon Gkalpakiotis, Martina Kojanová, Jorga Fialová, et al.
Dermatology and Therapy (2023) Vol. 14, Iss. 1, pp. 115-130
Open Access
